“…These biomarkers have shown diagnostic and prognostic value in native kidney diseases in clinical and experimental settings. [9][10][11][12][13][14] Thus, such enzymes as N-acetyl-β-D-hexosaminidase (NAG), [15][16][17][18] γ-glutamyl transpeptidase (GGT), 16,[19][20][21] and alkaline phosphatase (AP) 19,20 have been proposed for in-depth assessment of the KAG state. However, most published studies on these biomarkers in KAG recipients were limited to the early posttransplant period 16,18,20,22,23 and focused on the diagnosis of acute tubular necrosis, 16,18,20,22,23 acute graft rejection, 16,20,23 or nephrotoxicity.…”